Tamir Polikar - Delek Deputy VP
| DLEKG Stock | ILS 48,860 2,000 4.27% |
Insider
Tamir Polikar is Deputy VP of Delek Group
| Age | 58 |
| Phone | 972 9 863 8444 |
| Web | https://www.delek-group.com |
Delek Management Efficiency
The company has return on total asset (ROA) of 0.1649 % which means that it generated a profit of $0.1649 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.7063 %, meaning that it generated $0.7063 on every $100 dollars invested by stockholders. Delek's management efficiency ratios could be used to measure how well Delek manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Yizhak Eliav | El Al Israel | 48 | |
| Avivit Klein | Bank Leumi Le Israel | 54 | |
| Ziv CPA | Bank Leumi Le Israel | 52 | |
| Tobi Fischbein | Bezeq Israeli Telecommunication | 50 | |
| Leehu Hacohen | El Al Israel | N/A | |
| David Paulson | Bank Leumi Le Israel | 60 | |
| Eli Shani | Teva Pharmaceutical Industries | N/A | |
| Zvika Abramovich | Bezeq Israeli Telecommunication | N/A | |
| Andrew Weil | Teva Pharmaceutical Industries | 52 | |
| Kathleen Veit | Teva Pharmaceutical Industries | N/A | |
| Shmulik Arbel | Bank Leumi Le Israel | 54 | |
| Amit Kurland | Bezeq Israeli Telecommunication | 52 | |
| Naftali Sternlicht | Bezeq Israeli Telecommunication | N/A | |
| Ilan Sigal | Bezeq Israeli Telecommunication | 48 | |
| Amir Weiss | Teva Pharmaceutical Industries | 46 | |
| Eliav David | Bank Leumi Le Israel | N/A | |
| Raja Dakkuri | Bank Leumi Le Israel | 52 | |
| Janet Vergis | Teva Pharmaceutical Industries | 54 | |
| Shahar Aha | Fattal 1998 Holdings | 52 | |
| Kare Schultz | Teva Pharmaceutical Industries | 62 | |
| Abbas Hussain | Teva Pharmaceutical Industries | 54 | |
Management Performance
| Return On Equity | 0.71 | |||
| Return On Asset | 0.16 |
Delek Group Leadership Team
Elected by the shareholders, the Delek's board of directors comprises two types of representatives: Delek inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Delek. The board's role is to monitor Delek's management team and ensure that shareholders' interests are well served. Delek's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Delek's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Leora Levin, Chief General Counsel, Executive VP and Secretary | ||
| Lena Bernstein, Chief Accountant | ||
| Gilad Meirson, Chairman Limited | ||
| Yitzhak Oz, CoChief Ltd | ||
| Tamir Polikar, Deputy VP | ||
| Gali Gana, Internal Auditor | ||
| Yossi Abu, Chief Ltd | ||
| Stu Schapiro, CoChief Ltd | ||
| Advocate Wallace, Pres CEO | ||
| Moni Feller, CoChief Ltd |
Delek Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Delek a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.71 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.48 % | |||
| Operating Margin | 0.96 % | |||
| Current Valuation | 23.6 B | |||
| Shares Outstanding | 17.78 M | |||
| Shares Owned By Insiders | 48.72 % | |||
| Shares Owned By Institutions | 8.37 % | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 0.69 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Delek Stock Analysis
When running Delek's price analysis, check to measure Delek's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delek is operating at the current time. Most of Delek's value examination focuses on studying past and present price action to predict the probability of Delek's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delek's price. Additionally, you may evaluate how the addition of Delek to your portfolios can decrease your overall portfolio volatility.